Site 0243 - Mark H Zangmeister Cancer Center — Columbus, Ohio

Site 0243 - Mark H Zangmeister Cancer Center is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 0243 - Mark H Zangmeister Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Columbus

Browse all research sites in Ohio · View every site in Columbus

• Ohio State University Wexner Medical Center - Outpatient Care East
• Division of Radiation Oncology, The Ohio State University Wexner
• Mount Caramel East Hospital
• The Ohio State University Wexner Medical Center - Martha Morehouse Medical Pavilion
• The Wright Center of Innovation- The Ohio State University
• Ohio State University Wexner Medical Center: Division of Nephrology
• The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Solove Research Institute
• The University of Ohio
• University Hospital East Ohio State University Medical Center
• Division of Cardiology - The Ohio State University Medical Center
• Ohio State University Med Ctr; MS Center
• Ohio State University, Ohio State University Medical Center The Richard M Ross Heart Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 0243 - Mark H Zangmeister Cancer Center?

Site 0243 - Mark H Zangmeister Cancer Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 0243 - Mark H Zangmeister Cancer Center conducted?

Site 0243 - Mark H Zangmeister Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Is Site 0243 - Mark H Zangmeister Cancer Center accredited by Crixeo Clinical Trials?

Site 0243 - Mark H Zangmeister Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 0243 - Mark H Zangmeister Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.